PHARMAC has distributed over 1.26 million doses of the influenza vaccine this winter.
PHARMAC has made a decision to make changes to the funding of etanercept, a biologic medicine used to reduce chronic inflammation and treat immune-mediated conditions such as arthritis and psoriasis, from 1 July 2019.
The 2019 Tapuhi Kaitiaki Awards, jointly awarded by PHARMAC and Te Rūnanga o Aotearoa/New Zealand Nurses Organisation (NZNO) and presented in August will both celebrate and support Māori nurses to continue in their studies and improve their clinical practice. Nominations/applications are now open.
Proposal to list endomechanical and electrosurgical medical devices supplied by Device Technologies Australia Pty Ltd
PHARMAC is seeking feedback on a proposal to list a range of endomechanical and electrosurgical medical devices on Section H Part III of the Pharmaceutical Schedule from 1 August 2019 through a listing agreement with Device Technologies Australia Pty Ltd.
Closes: 5pm, Wednesday 26 June 2019.
PHARMAC is notifying of an amendment to the March 2019 Tender Notification. The notification omitted information about the timing of the change in price for chloramphenicol eye drops in Section B and Section H of the Pharmaceutical Schedule.
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2018/19 Invitation to Tender, dated 1 November 2018.
Decision to list surgical suction, chest and wound drainage products supplied by Culpan Distributors Limited
We are pleased to announce the approval of a listing agreement for surgical suction, chest and wound drainage medical devices with Culpan Distributors Limited (‘Culpan’).
Proposals for funding in the neurology, immunosuppressants, diabetes and antithrombotic therapy areas
We are seeking feedback on proposals for funding in the neurology, immunosuppressant, diabetes and antithrombotic therapy areas.
Closes: 5pm on Friday, 14 June 2019.
Decision to list patient warming and cooling medical devices supplied by Draeger New Zealand Limited
We are pleased to announce the approval of a listing agreement with Draeger New Zealand Limited for the supply of patient warming and cooling products to DHBs.
Request dated 11 March 2019, for information relating to treatments for rare disorders, breast cancer treatment and venlafaxine.
Over 1500 New Zealanders have started a new hepatitis C treatment in the last three months that could dramatically change their lives.
Request for a summary of factors determining CPB expenditure for the 2016/17 and 2017/18 financial years, based upon previously published information in PHARMAC’s annual reports.
Request for information relating to PrEP (emtricitabine with tenofovir), which is Pre-Exposure Prophylaxis. PrEP is a daily pill for people who do not have HIV to prevent HIV.
Request dated 26 March 2019 for information relating to adrenaline autoinjectors.
Request dated 28 March 2019 for information relating to Daivobet Gel.
We are pleased to announce the approval of non-exclusive listing agreements with 3M New Zealand Limited and Protec Solutions Limited for the supply of continence and urology products to DHBs.
Decision to list medical devices in the endomechanical and electrosurgical category supplied by Ortho Medics Limited
We’re pleased to announce the approval of an amendment to the listing agreement for medical devices with Ortho Medics Limited to include products in the endomechanical and electrosurgical category of medical devices.
PHARMAC is seeking feedback on a proposal to list a range of obstetrics and gynaecology products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019 through a provisional agreement with Pro-Med Technologies Limited.
Closes: 4pm Thursday, 6 June 2019.
PHARMAC is seeking feedback on a proposal to widen access to funded pertussis (whooping cough) vaccine for all pregnant women at any time during their pregnancy, as well as for parents of infants admitted to a Neonatal Intensive Care Unit or Specialist Care Baby Unit for more than 3 days.
Closes: 5pm on Tuesday, 4 June 2019.
PHARMAC is seeking feedback on a proposal to list a range of continence products in Part III of Section H of the Pharmaceutical Schedule from 1 July 2019, through a listing agreement with Smith & Nephew Limited.
Closes: 4pm Friday, 31 May 2019.